Efficacy and Safety of Chinese Patent Medicine Combined With Oseltamivir in Treatment of Children With Influenza: A meta-Analysis
Background: Recently, Chinese patent medicines (CPMs) have been widely used to treat children with influenza in China, with curative effects. Therefore, the efficacy and safety of such treatment require further evaluation. The present meta-analysis integrated data from several independent studies to...
Main Authors: | Nai-fan Duan, Bin Liu, Xiao-na Li, Yi-bai Xiong, Yan Zhang, Chi Zhang, Li LI, Cheng Lu, Jueni Lyu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-08-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.682732/full |
Similar Items
-
Occurrence and characterization of oseltamivir-resistant influenza virus in children between 2007-2008 and 2008-2009 seasons
by: Seoung Geun Kim, et al.
Published: (2013-04-01) -
Debate Regarding Oseltamivir Use for Seasonal and Pandemic Influenza
by: Aeron C. Hurt, et al.
Published: (2016-06-01) -
Effectiveness of Oseltamivir in reducing 30-day readmissions and mortality among patients with severe seasonal influenza in Australian hospitalized patients
by: Yogesh Sharma, et al.
Published: (2021-03-01) -
Inhibitory activity of selenium nanoparticles functionalized with oseltamivir on H1N1 influenza virus
by: Li Y, et al.
Published: (2017-08-01) -
Clinical Effectiveness of Intravenous Peramivir versus Oseltamivir for the Treatment of Influenza in Hospitalized Patients
by: Lee JS, et al.
Published: (2020-05-01)